Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy

Blockade of the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) interaction is currently the focus in the field of cancer immunotherapy, and so far, several monoclonal antibodies (mAbs) have achieved encouraging outcomes in cancer treatment. Despite this achievement, mAbs-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongbo, Xia, Yu, Yu, Chunqiu, Du, Huijie, Liu, Jinchang, Li, Hui, Huang, Shihui, Zhu, Qihua, Xu, Yungen, Zou, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199613/
https://www.ncbi.nlm.nih.gov/pubmed/34199417
http://dx.doi.org/10.3390/molecules26113347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199613/
https://www.ncbi.nlm.nih.gov/pubmed/34199417
http://dx.doi.org/10.3390/molecules26113347

Ejemplares similares